Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Pockros

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Gastroenterology|December 25, 2010
New direct-acting antivirals in the development for hepatitis C virus infectionPaul J Pockros
Journal of Clinical Gastroenterology|July 11, 2006
Noninvasive markers of fibrosis in chronic hepatitis patientsPaul J Pockros
Expert Review of Gastroenterology & Hepatology|December 17, 2008
New drugs for hepatitis C virusPaul J Pockros
Clinics in Liver Disease|July 25, 2009
Novel therapies in Hepatitis C virus. PrefacePaul J Pockros
Gastroenterology & Hepatology|October 18, 2017
Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV InfectionPaul J Pockros
Drugs|February 16, 2011
Drugs in development for viral hepatitis: care and cautionPaul J Pockros
Clinics in Liver Disease|November 27, 2012
Non-nucleoside analogue polymerase inhibitors in developmentPaul J Pockros
Clinics in Liver Disease|November 27, 2012
Novel and combination therapies for hepatitis C virusPaul J Pockros
Clinics in Liver Disease|July 25, 2009
Antifibrotics for chronic hepatitis CPaul J Pockros
Clinical Liver Disease|April 18, 2019
The dawn of a new era in the treatment of HCV infection: A view from the USAPaul J Pockros
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Gastroenterology|December 25, 2010
New direct-acting antivirals in the development for hepatitis C virus infectionPaul J Pockros
Journal of Clinical Gastroenterology|July 11, 2006
Noninvasive markers of fibrosis in chronic hepatitis patientsPaul J Pockros
Expert Review of Gastroenterology & Hepatology|December 17, 2008
New drugs for hepatitis C virusPaul J Pockros
Clinics in Liver Disease|July 25, 2009
Novel therapies in Hepatitis C virus. PrefacePaul J Pockros
Gastroenterology & Hepatology|October 18, 2017
Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV InfectionPaul J Pockros
Drugs|February 16, 2011
Drugs in development for viral hepatitis: care and cautionPaul J Pockros
Clinics in Liver Disease|November 27, 2012
Non-nucleoside analogue polymerase inhibitors in developmentPaul J Pockros
Clinics in Liver Disease|November 27, 2012
Novel and combination therapies for hepatitis C virusPaul J Pockros
Clinics in Liver Disease|July 25, 2009
Antifibrotics for chronic hepatitis CPaul J Pockros
Clinical Liver Disease|April 18, 2019
The dawn of a new era in the treatment of HCV infection: A view from the USAPaul J Pockros
Pageof 11